Inhibitors of tripeptidyl peptidase II. 3. Derivation of butabindide by successive structure optimizations leading to a potential general approach to designing …

…, L Zhao, P Bourgeat, C Rose, F Vargas…

Index: Ganellin, C. Robin; Bishop, Paul B.; Bambal, Ramesh B.; Chan, Suzanne M. T.; Leblond, Bertrand; Moore, Andrew N. J.; Zhao, Lihua; Bourgeat, Pierre; Rose, Christiane; Vargas, Froylan; Schwartz, Jean-Charles Journal of Medicinal Chemistry, 2005 , vol. 48, # 23 p. 7333 - 7342

Full Text: HTML

Citation Number: 10

Abstract

The cholecystokinin-8 (CCK-8)-inactivating peptidase is a serine peptidase that has been shown to be a membrane-bound isoform of tripeptidyl peptidase II (EC 3.4. 14.10). It cleaves the neurotransmitter CCK-8 sulfate at the Met-Gly bond to give Asp-Tyr (SO3H)-Met-OH+ Gly- Trp-Met-Asp-Phe-NH2. Starting from Val-Pro-NHBu, a dipeptide of submicromolar affinity that had previously been generated to serve as a lead, successive optimization at P3, P1, ...

Related Articles:

(Phosphinyloxy) acyl amino acid inhibitors of angiotensin converting enzyme. 2. Terminal amino acid analogs of (S)-1-[6-amino-2-[[hydroxy (4-phenylbutyl) phosphinyl …

[Journal of Medicinal Chemistry, , vol. 33, # 5 p. 1459 - 1469]

Synthesis and pharmacological activity of angiotensin-converting enzyme inhibitors: N-(mercaptoacyl)-4-substituted-(S)-prolines

[Smith, Elisabeth M.; Swiss, Gerald F.; Neustadt, Bernard R.; Gold, Elijah H.; Sommer, Jane A.; et al. Journal of Medicinal Chemistry, 1988 , vol. 31, # 4 p. 875 - 885]

More Articles...